Prospective multicenter registration of major late sequelae in sarcoma patients using the Late Effects Surveillance System (LESS)

Klinische Padiatrie

Volumn 217, Issue 3, 2005, Pages 176-181

  Langer, T ^a   Stohr W ^a   Paulides, M ^a   Kremers, A ^a   Dorr H G ^a   Gobel U ^b   Beck, J D ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

Childhood cancer survivors; Long term sequelae; Sarcoma

Indexed keywords

ADOLESCENT; ARTICLE; CANCER PATIENT; CANCER REGISTRY; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CLINICAL TRIAL; EWING SARCOMA; FEMALE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OSTEOSARCOMA; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK ASSESSMENT; SARCOMA; SOFT TISSUE SARCOMA; SURVIVAL TIME;

ADOLESCENT; ADULT; AGE FACTORS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE NEOPLASMS; CHILD; CLINICAL TRIALS; FOLLOW-UP STUDIES; GERMANY; HUMANS; MULTICENTER STUDIES; OSTEOSARCOMA; POPULATION SURVEILLANCE; PRACTICE GUIDELINES; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; REGISTRIES; SARCOMA; SARCOMA, EWING'S; SURVIVORS; TIME FACTORS;

EID: 18944388288     PISSN: 03008630     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-836503     Document Type: Article

References (29)

1. Beck JD, Winkler K, Niethammer D, Brandis M, Hertzberg H, der Hardt K von, Greil J, Uberall MA, Rossi R, Lamprecht-Dinnesen A. After-care of children and young adults surviving cancer. Initial recommendations by the late sequelae study group. Klin Padiatr 1995; 207: 186-192
2. Beck JD, Hertzberg H, Kochendörfer S, Meier W, Göbel U, Greil J, Langer T. Neuropsychologische Spätfolgen nach Behandlung einer akuten lymphoblastischen Leukämie im Kindesalter. Klin Onkol 1997; Sonderband der PRAXIS Schweizerische Rundschau für Medizin: 11-15
3. Bielack S, Beck JD, Winkler K. Spätfolgen nach Krebsbehandlung im Kindesalter. Monatsschr Kinderheilkd 1995; 143: 649-657
4. Blatt J, Copeland D, Bleyer W. Late effects of childhood cancer and its treatment. In: Pizzo P, Poplack D (Hrsg.) Principles and Practice of Paediatric Oncology, Lippincott-Raven Publishers, Philadelphia 1997; 1303-1329
5. Cooperative Osteosarkomstudie. COSS-96 Studienprotokoll. Dr. Stefan Bielack, Abteilung für pädiatrische Hämatologie und Onkologie der Universitätsklinik Hamburg-Eppendorf, Martinistr. 52, D-20246 Hamburg
6. Cooperative Weichteilsarkom Studie. CWS-96 Studienprotokoll. CWS-Studie, Olgahospital Stuttgart, Bismarckstr. 8, 70176 Stuttgart
7. Creutzig U, Zimmermann M, Hannemann J, Kramer I, Herold R, Henze G. Quality management within the competence network of paediatric oncology and haematology. Klin Padiatr 2003; 215: 338-340
8. Creutzig U, Jürgens H, Herold R, Gobel U, Henze G. Concepts of the Society of Paediatric Oncology and Haematology (GPOH) and the German Competence Network in Paediatric Oncology and Haematology for the quality controlled development in paediatric oncology. Klin Padiatr 2004; 216: 379-383
9. European Ewing tumour Working Initiative of National Groups Ewing Tumour Studies 1999. EURO-E.W.I.N.G. 99 Study Protocol. Dr. Michael Paulussen, Dept. Paed. Haematol./Oncology, Univ. of Muenster, Albert-Schweizer-Str. 33, D-48129 Muenster, Germany
10. Geidel S, Garn M, Gravinghoff L, Hausdorf G, Morf G, Bielack S, Knop J, Winkler K. Cardiomyopathy after osteosarcoma treatment: a contribution to the cardiotoxicity of adriamycin. Klin Padiatr 1991; 203: 257-261
11. Göbel U, Jürgens H. Transferring disease-oriented basic research into pediatric oncology. Klin Padiatr 2003; 215: 289-290
12. Göbel U, Kulozik AE. Scientific results in paediatric oncology and haematology. Klin Padiatr 2004; 216: 301-303
13. Graf N, Göbel U. Clinical trials and studies of the German Society for Paediatric Oncology and Haematology (GPOH) and the European Directive for the Implementation of Good Clinical Practice in the Conduct of Clinical Trials. Klin Padiatr 2004; 216: 129-131
14. Hartmann S, Schäper E, Lamprecht-Dinnesen A, Boos J. Ototoxizität von Cisplatin im Kindesalter. Otorhinolaryngol Nova 1995; 5: 222-230
15. Hertzberg H, Huk WJ, Ueberall MA, Langer T, Meier W, Dopfer R, Skalej M, Lackner H, Bode U, Janssen G, Zintl F, Beck JD. CNS late effects after ALL therapy in childhood. Parti: Neuroradiological findings in long-term survivors of childhood ALL - an evaluation of the interferences between morphology and neuropsychological performance. The German Late Effects Working Group. Med Pediatr Oncol 1997; 28: 387-400
16. Kaatsch P, Michaelis J. Second neoplasms after malignant diseases in childhood. Klin Padiatr 1995; 207: 158-163
17. Langer T, Hertzberg H, Dörr HG, Greil J, Beck JD. Prinzipien zur Erfassung von Spätfolgen. In: Henze G (Hrsg). Diagnostische und therapeutische Standards in der pädiatrischen Onkologie. Zuckschwerdt-Verlag, München, Bern, Wien, New York 1998
18. Langer T, Krappmann P, Kochendörfer S, Kusch M, Göbel U, Huk W, Martus P, Beck JD. The late effects of prophylactic CNS treatment. In: Büchner T et al. (eds). Acute leukemias VIII: prognostic factors and treatment strategies. Springer, Berlin, Heidelberg, New York 2001; 370-380
19. Langer T, Führer M, Stöhr W, Dörffel W, Dörr HG, Bielack S, Rossi R, Kaatsch P, Beck JD. Die Überlebenden einer Krebserkrankung im Kindesalter. Monatsschr Kinderheilkd 2002; 8: 942-953
20. Langer T, Martus P, Ottensmeier H, Hertzberg H, Beck JD, Meier W. CNS late-effects after ALL-therapy in childhood Part III: Neuropsychological performance in long-term survivors of childhood ALL. Impairments of distractibility, attention and memory and its interferences to CNS morphology. Med Pediatr Oncol 2002; 38: 320-328
21. Langer T, Stöhr W, Bielack S, Paulussen M, Treuner J, Beck JD. Late effects surveillance system for sarcoma patients. Pediatr Blood Cancer 2004; 42: 373-379
22. Marx M, Beck JD, Müller HL, Kühl J, Langer T, Dörr HG. Endocrine late-effects of brain tumour therapy in childhood and adolescence: concept of a prospective endocrinological follow-up. Klin Padiatr 2000; 212: 224-228
23. Marx M, Langer T, Graf N, Hausdorf G, Stöhr W, Ludwig R, Beck JD. Multicentre analysis of anthracycline-induced cardiotoxicity in children following treatment according to the nephroblastoma studies SIOP N0.9/GPOH and SIOP 93-01/GPOH. Med Pediatr Oncol 2002; 39: 18-24
24. Mertens AC, Yasui Y, Neglia JP, Potter JD, Nesbit M-EJ, Ruccione K, Smithson WA, Robison LL. Late mortality experience in five-year survivors of childhood and adolescent cancer: the Childhood Cancer Survivor Study. J Clin Oncol 2001; 19: 3163-3172
25. Moller TR, Garwicz S, Barlow L, Falck-Winther J, Glattre E, Olafsdottir G, Olsen JH, Perfekt R, Ritvanen A, Sankila R, Tulinius H. Decreasing late mortality among five-year survivors of cancer in childhood and adolescence: a population-based study in the Nordic countries. J Clin Oncol 2001; 19: 3173-3181
26. Paulussen M, Ahrens S, Braun-Munzinger G, Craft AW, Dockhorn-Dworniczak B, Dörffel W, Dunst J, Fröhlich B, Göbel U, Haussler M, Klingebiel T, Koscielniak E, Mittler U, Rube C, Winkelmann W, Voute PA, Zoubek A, Jurgens H. EICESS 92 (European Intergroup Cooperative Ewing's Sarcoma Study) - preliminary results. Klin Padiatr 1999; 211: 276-283
27. Rossi R, Kleinebrand A, Godde A, Rath B, Jürgens H. Increased risk of ifosfamide-induced renal Fanconi's syndrome after unilateral nephrectomy. Lancet 1993; 341: 755
28. Steinherz LJ, Graham T, Hurwitz R, Sondheimer HM, Schwartz RG, Shaffer EM, Sandor G, Benson L, Williams R. Guidelines for cardiac monitoring of children during and after anthracycline therapy: report of the Cardiology Committee of the Childrens Cancer Study Group. Pediatrics 1992; 89: 942-949
29. Stöhr W, Langer T, Kremers A, Bielack S, Dinnesen A, Frey E, Beck JD. Cisplatin-induced ototoxicity in osteosarcoma patients: A report from the Late Effects Surveillance System. Cancer Investigation 2005; (in press)